Virtual reality workouts could rebuild strength in MS patients
NCT ID NCT07738120
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This trial tests whether a six-month program of high-intensity exercise delivered through an immersive virtual reality headset can improve mobility, strength, and thinking skills in people with multiple sclerosis (MS). Participants will be randomly assigned to either the VR exercise program or standard rehabilitation. The study measures changes in disability, walking speed, hand dexterity, cognitive processing, and fatigue to see if this novel approach is safe and beneficial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A supervised virtual reality exercise program using an immersive VR headset
- What this could lead to
- If effective, this approach could offer an engaging, safe way for people with MS to improve physical function and quality of life.
- What could go wrong
- The trial is small (30 participants) and early, so results may not apply broadly. VR may cause discomfort or dizziness in some users.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXERCISE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Vigo
RECRUITINGPontevedra, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Water workouts could be the key to back pain relief
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?